Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Cabaletta Bio, Inc. (CABA)
USD2.71
+0.04 (+1.58%)
US NASDAQ Healthcare Biotechnology
Address
2929 Arch Street 19104
Philadelphia, PA, US
Philadelphia, PA, US
CEO
Steven A. Nichtberger
Website
cabalettabio.com
IPO
2019-10-25
CIK 1759138 ISIN US12674W1099
Description
Cabaletta Bio, Inc. is a biotechnology firm in the clinical development stage, specializing in the invention and advancement of sophisticated engineered T cell therapies. Its core mission is to treat autoimmune diseases where B cells are implicated in producing harmful autoantibodies. The company's unique chimeric autoantibody receptor (CAAR) T cell platform is engineered to precisely target and eradicate these specific disease-causing B cells. Leading its pipeline is DSG3-CAART, which is currently in Phase I clinical trials. This candidate is being assessed for efficacy in two distinct conditions: mucosal pemphigus vulgaris, an autoimmune blistering skin disorder, and Hemophilia A in patients exhibiting Factor VIII alloantibodies. Cabaletta's broader product candidate portfolio also includes MuSK-CAART, a preclinical asset aimed at a particular subset of myasthenia gravis patients; FVIII-CAART, in the discovery phase for another subgroup of Hemophilia A sufferers; and DSG3/1-CAART, also a discovery-stage program, designed for mucocutaneous pemphigus vulgaris. The company maintains strategic alliances, including a collaboration with the University of Pennsylvania and a research pact with The Regents of the University of California. Founded in 2017 as Tycho Therapeutics, Inc., it adopted the name Cabaletta Bio, Inc. in August 2018 and is based in Philadelphia, Pennsylvania.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD2.71
+0.04 (+1.58%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
4M
Beta
3.23
Float Shares
84.30M
Free Float %
87.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -8.31% | -14.69% | -3.78% | +11.82% | +38.49% | +51.14% | +72.40% | -72.71% | -64.56% | -66.90% | -66.90% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (12 ratings, all time)
Buy
Price Targets & DCF
Current price
2.71
Low
3.00
+10.6%
Consensus
16.33
+502.1%
Median
14.00
+416.2%
High
32.00
+1,079.9%
DCF (Unlevered)
0.49
-81.9%
DCF (Levered)
0.55
-79.9%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
80% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 7 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | — | — |
| All Time | 3 |
16.33
+502.1%
|
Quality scores
Altman Z-Score
-4.41
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+29.9% ★ Q1'26: +46.6% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%-3,103.4% Q1'26: -1,350.5% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+106.7% Q1'26: +126.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.16× Q1'26: -0.15× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 6 EPS Ana. |
Dec 2027 7 Rev. Ana. 4 EPS Ana. |
Dec 2028 8 Rev. Ana. 7 EPS Ana. |
Dec 2029 7 Rev. Ana. 2 EPS Ana. |
Dec 2030 7 Rev. Ana. 5 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
—
|
—
est: 4.38M (-100.0%)
|
2.50M
2.50M – 2.50M
-42.9% YoY
|
712.6K
712.6K – 712.6K
-71.5% YoY
|
63.68M
63.68M – 63.68M
+8,836.7% YoY
|
345.68M
345.68M – 345.68M
+442.8% YoY
|
787.60M
787.60M – 787.60M
+127.8% YoY
|
| EBITDA |
-110.30M
|
-170.60M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-115.12M
|
-172.24M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-115.86M
est: -116.44M (+0.5%)
|
-167.86M
est: -225.95M (+25.7%)
|
-135.16M
-167.14M – -103.17M
+40.2% YoY
|
-129.39M
-151.98M – -106.79M
+4.3% YoY
|
-240.24M
-254.01M – -49.23M
-85.7% YoY
|
-66.47M
-66.47M – -66.47M
+72.3% YoY
|
85.39M
85.39M – 85.39M
+228.5% YoY
|
| SGA |
23.13M
|
29.57M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-2.34
est: -2.34 (-0.1%)
|
-1.64
est: -2.19 (+25.1%)
|
-1.38
-1.63 – -1.01
+36.9% YoY
|
-1.27
-1.49 – -1.04
+8.5% YoY
|
-1.17
-2.48 – -0.48
+7.6% YoY
|
-0.65
-0.65 – -0.65
+44.4% YoY
|
0.84
0.84 – 0.84
+228.5% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-15 | Wells Fargo | Equal Weight | Equal Weight | Maintain |
| 2026-05-04 | Cantor Fitzgerald | Overweight | Overweight | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-14 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-13 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-12 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-11 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-05 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-04 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-01 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-29 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
61
Total invested
65.51M
Insider transactions (90d)
0
Beneficial owners (>5%)
29
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1) BlackRock, Inc. | 4.41M | 10.30% | 4.38M | — | 4.41M | — | HC | Delaware | 2024-01-08 | ↗ |
| 2 | 85-4328500 | 3.67M | 7.50% | 3.67M | — | 3.67M | — | IA | Maryland | 2024-11-14 | ↗ |
| 3 | 13-3017981 | 3.48M | 11.90% | 3.48M | — | 3.48M | — | HC | New York | 2023-02-10 | ↗ |
| 4 | Bain Capital Life Sciences Opportunities III, LP | 2.76M | 5.70% | — | 2.76M | — | 2.76M | PN | Delaware | 2024-08-22 | ↗ |
| 5 | STATE STREET CORPORATION | 2.59M | 6.05% | — | 2.52M | — | 2.59M | HC | BOSTON, MASSACHUSETTS | 2024-01-24 | ↗ |
| 6 | Company, L.P. | 2.34M | 5.90% | — | 2.34M | — | — | PN | Delaware | 2023-05-26 | ↗ |
| 7 | James E. Flynn | 2.34M | 5.90% | — | 2.34M | — | — | IN | Delaware | 2023-05-26 | ↗ |
| 8 | Bihua Chen | 2.00M | 7.81% | — | 2.00M | — | — | IN | United States | 2022-10-31 | ↗ |
| 9 | Koh, Bong | 1.90M | 6.50% | — | 1.90M | — | — | IN | United States | 2022-12-23 | ↗ |
| 10 | Shah, Nimish | 1.90M | 6.50% | — | 1.90M | — | — | IN | United States | 2022-12-23 | ↗ |
| 11 | VHCP Co-Investment Holdings III, LLC | 1.90M | 6.50% | — | 1.90M | — | — | OO | United States | 2022-12-23 | ↗ |
| 12 | VHCP Management EG, LLC | 1.90M | 6.50% | — | 1.90M | — | — | OO | United States | 2022-12-23 | ↗ |
| 13 | VHCP Management III, LLC | 1.90M | 6.50% | — | 1.90M | — | — | OO | United States | 2022-12-23 | ↗ |
| 14 | Venrock Healthcare Capital Partners EG, L.P. | 1.90M | 6.50% | — | 1.90M | — | — | PN | United States | 2022-12-23 | ↗ |
| 15 | Venrock Healthcare Capital Partners III, L.P. | 1.90M | 6.50% | — | 1.90M | — | — | PN | United States | 2022-12-23 | ↗ |
| 16 | Deerfield Mgmt, L.P. | 1.88M | 4.73% | — | 1.88M | — | — | PN | Delaware | 2023-05-26 | ↗ |
| 17 | Deerfield Partners, L.P. | 1.88M | 4.73% | — | 1.88M | — | — | PN | Delaware | 2023-05-26 | ↗ |
| 18 | Steven Nichtberger | 1.86M | 6.40% | 1.86M | — | 1.86M | — | IN | United States of America | 2022-11-07 | ↗ |
| 19 | Capital LP | 1.46M | 5.00% | — | 1.46M | — | 1.46M | IA | Delaware, USA | 2023-01-13 | ↗ |
| 20 | Capital Master LP | 1.46M | 5.00% | — | 1.46M | — | 1.46M | OO | Delaware, USA | 2023-01-13 | ↗ |
| 21 | Baker Bros. Advisors (GP) LLC | 1.34M | 5.20% | 1.34M | — | 1.34M | — | HC, OO | Delaware | 2023-02-14 | ↗ |
| 22 | Baker Bros. Advisors LP | 1.34M | 5.20% | 1.34M | — | 1.34M | — | IA, PN | — | 2023-02-14 | ↗ |
| 23 | Felix J. Baker | 1.34M | 5.20% | 1.34M | — | 1.34M | — | HC, IN | — | 2023-02-14 | ↗ |
| 24 | Julian C. Baker | 1.34M | 5.20% | 1.34M | — | 1.34M | — | HC, IN | — | 2023-02-14 | ↗ |
| 25 | Cormorant Private Healthcare Fund II, LP | 1.15M | 4.51% | — | 1.15M | — | — | PN | Delaware | 2022-10-31 | ↗ |
| 26 | Cormorant Private Healthcare GP II, LLC | 1.15M | 4.51% | — | 1.15M | — | — | OO | Delaware | 2022-10-31 | ↗ |
| 27 | Cormorant Global Healthcare GP, LLC | 845.6K | 3.30% | — | 845.6K | — | — | OO | Delaware | 2022-10-31 | ↗ |
| 28 | Deerfield Mgmt IV, L.P. | 464.3K | 1.17% | — | 464.3K | — | — | PN | Delaware | 2023-05-26 | ↗ |
| 29 | Deerfield Private Design Fund IV, L.P. | 464.3K | 1.17% | — | 464.3K | — | — | PN | Delaware | 2023-05-26 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
61
-37 vs prev Q
New positions
17
Closed positions
52
Increased
33
Reduced
11
Put/Call ratio
0.16
Calls held
172.8K
Puts held
27.3K
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 505.4K +505.4K (+100.0%) | 1.11B +1.1B (+100.0%) | 0.49% +0.494 pp | 1.07% +1.071 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 2 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 9.86M +1.5M (+17.9%) | 21.59M +2.0M (+10.3%) | 9.64% +1.463 pp | 0.01% +0.002 pp | USD7.16 -69.4% | 9 qtrs — |
| 3 | BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 9.68M +— (+0.0%) | 21.19M -1.5M (-6.4%) | 9.46% +0.000 pp | 1.62% +0.120 pp | USD3.81 -42.5% | 11 qtrs — |
| 4 | JENNISON ASSOCIATES LLC | 8.91M +408.2K (+4.8%) | 19.50M -380.8K (-1.9%) | 8.71% +0.399 pp | 0.01% +0.000 pp | USD4.62 -52.6% | 12 qtrs — |
| 5 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 8.83M +— (+0.0%) | 19.34M -1.3M (-6.4%) | 8.63% +0.000 pp | 0.03% -0.004 pp | USD5.77 -62.0% | 25 qtrs — |
| 6 | VANGUARD GROUP INC | 4.42M +228.7K (+5.5%) | 9.68M -127.8K (-1.3%) | 4.32% +0.224 pp | 0.00% +0.000 pp | USD7.17 -69.5% | 25 qtrs — |
| 7 | CORMORANT ASSET MANAGEMENT, LP | 4.40M -600.0K (-12.0%) | 9.64M -2.1M (-17.6%) | 4.30% -0.587 pp | 0.45% -0.362 pp | USD1.52 +44.1% | 3 qtrs — |
| 8 | MILLENNIUM MANAGEMENT LLC | 2.74M +2.1M (+298.5%) | 5.99M +4.4M (+273.0%) | 2.68% +2.005 pp | 0.00% +0.002 pp | USD2.37 -7.6% | 8 qtrs — |
| 9 | BLACKROCK, INC. | 2.33M +707.6K (+43.7%) | 5.10M +1.3M (+34.4%) | 2.28% +0.692 pp | 0.00% +0.000 pp | USD3.26 -32.8% | 6 qtrs — |
| 10 | SUPERSTRING CAPITAL MANAGEMENT LP | 2.25M +709.0K (+45.9%) | 4.94M +1.3M (+36.6%) | 2.20% +0.693 pp | 2.64% -0.918 pp | USD2.53 -13.4% | 8 qtrs — |
| 11 | TWO SIGMA INVESTMENTS, LP | 1.84M +1.4M (+291.1%) | 4.03M +2.9M (+266.0%) | 1.80% +1.339 pp | 0.01% +0.004 pp | USD2.67 -18.0% | 23 qtrs — |
| 12 | RENAISSANCE TECHNOLOGIES LLC | 1.52M +183.2K (+13.7%) | 3.33M +200.2K (+6.4%) | 1.49% +0.179 pp | 0.01% +0.001 pp | USD2.26 -3.1% | 5 qtrs — |
| 13 | MORGAN STANLEY | 1.34M -131.0K (-8.9%) | 2.94M -508.0K (-14.7%) | 1.31% -0.128 pp | 0.00% +0.000 pp | USD4.83 -54.7% | 25 qtrs — |
| 14 | WOODLINE PARTNERS LP | 1.25M -885.1K (-41.5%) | 2.74M -2.3M (-45.2%) | 1.22% -0.866 pp | 0.01% -0.013 pp | USD1.87 +17.1% | 3 qtrs — |
| 15 | SCHONFELD STRATEGIC ADVISORS LLC | 1.20M +159.9K (+15.3%) | 2.64M +193.6K (+7.9%) | 1.18% +0.156 pp | 0.01% -0.002 pp | USD1.50 +46.0% | 4 qtrs — |
| 16 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.09M -201.0K (-15.5%) | 2.40M -634.0K (-20.9%) | 1.07% -0.197 pp | 0.00% 0.000 pp | USD6.02 -63.6% | 11 qtrs — |
| 17 | GEODE CAPITAL MANAGEMENT, LLC | 1.09M +165.5K (+18.0%) | 2.38M +224.9K (+10.4%) | 1.06% +0.162 pp | 0.00% +0.000 pp | USD6.81 -67.8% | 25 qtrs — |
| 18 | MARSHALL WACE, LLP | 959.1K -367.0K (-27.7%) | 2.10M -1.0M (-32.3%) | 0.94% -0.359 pp | 0.00% -0.001 pp | USD2.50 -12.4% | 8 qtrs — |
| 19 | IKARIAN CAPITAL, LLC | 900.0K +900.0K (+100.0%) | 1.97M +2.0M (+100.0%) | 0.88% +0.880 pp | 0.15% +0.154 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 20 | OPALEYE MANAGEMENT INC. | 900.0K +91.1K (+11.3%) | 1.97M +78.2K (+4.1%) | 0.88% +0.089 pp | 0.26% -0.008 pp | USD2.32 -5.6% | 2 qtrs — |
| 21 | SCHRODER INVESTMENT MANAGEMENT GROUP | 756.6K +756.6K (+100.0%) | 1.63M +1.6M (+100.0%) | 0.74% +0.740 pp | 0.00% +0.001 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 22 | TWO SIGMA ADVISERS, LP | 737.9K +406.9K (+122.9%) | 1.62M +841.5K (+108.6%) | 0.72% +0.398 pp | 0.00% +0.002 pp | USD2.72 -19.5% | 7 qtrs — |
| 23 | BURKEHILL GLOBAL MANAGEMENT, LP | 700.0K +— (+0.0%) | 1.53M -105.0K (-6.4%) | 0.68% +0.000 pp | 0.10% +0.008 pp | USD1.52 +44.1% | 3 qtrs — |
| 24 | ENSIGN PEAK ADVISORS, INC | 550.0K +550.0K (+100.0%) | 1.20M +1.2M (+100.0%) | 0.54% +0.538 pp | 0.00% +0.002 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 25 | DIMENSIONAL FUND ADVISORS LP | 452.0K +452.0K (+100.0%) | 990.0K +990.0K (+100.0%) | 0.44% +0.442 pp | 0.00% +0.000 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 26 | RAIFFEISEN BANK INTERNATIONAL AG | 450.0K +100.0K (+28.6%) | 967.5K +134.5K (+16.1%) | 0.44% +0.098 pp | 0.01% +0.001 pp | USD2.10 +4.3% | 5 qtrs — |
| 27 | GOLDMAN SACHS GROUP INC | 430.7K +158.1K (+58.0%) | 943.2K +305.3K (+47.9%) | 0.42% +0.155 pp | 0.00% +0.000 pp | USD7.29 -70.0% | 24 qtrs — |
| 28 | STATE STREET CORP | 425.5K +48.7K (+12.9%) | 931.8K +50.1K (+5.7%) | 0.42% +0.048 pp | 0.00% +0.000 pp | USD9.72 -77.5% | 25 qtrs — |
| 29 | UBS GROUP AG | 415.7K +10.6K (+2.6%) | 910.3K -37.6K (-4.0%) | 0.41% +0.010 pp | 0.00% +0.000 pp | USD2.94 -25.5% | 14 qtrs — |
| 30 | 683 CAPITAL MANAGEMENT, LLC | 388.6K +388.6K (+100.0%) | 851.0K +851.0K (+100.0%) | 0.38% +0.380 pp | 0.04% +0.037 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 31 | ALMITAS CAPITAL LLC | 387.5K +— (+0.0%) | 848.6K -58.1K (-6.4%) | 0.38% +0.000 pp | 0.19% -0.021 pp | USD1.44 +52.1% | 4 qtrs — |
| 32 | QUBE RESEARCH & TECHNOLOGIES LTD | 331.2K +242.1K (+271.5%) | 725.4K +516.8K (+247.7%) | 0.32% +0.237 pp | 0.00% +0.001 pp | USD2.23 -1.8% | 2 qtrs — |
| 33 | GSA CAPITAL PARTNERS LLP | 304.0K +304.0K (+100.0%) | 666.0K +666.0K (+100.0%) | 0.30% +0.297 pp | 0.06% +0.057 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 34 | BOOTHBAY FUND MANAGEMENT, LLC | 243.4K +243.4K (+100.0%) | 533.1K +533.1K (+100.0%) | 0.24% +0.238 pp | 0.01% +0.008 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 35 | NORTHERN TRUST CORP | 238.4K +11.5K (+5.0%) | 522.2K -9.0K (-1.7%) | 0.23% +0.011 pp | 0.00% +0.000 pp | USD7.26 -69.8% | 25 qtrs — |
| 36 | CITADEL ADVISORS LLC | 222.6K -22.2K (-9.1%) | 487.5K -85.3K (-14.9%) | 0.22% -0.022 pp | 0.00% +0.000 pp | USD2.49 -12.0% | 14 qtrs — |
| 37 | BARCLAYS PLC | 220.7K +159.6K (+261.0%) | 483.3K +194.8K (+67.5%) | 0.22% +0.117 pp | 0.00% +0.000 pp | USD2.68 -18.3% | 16 qtrs — |
| 38 | INVESCO LTD. | 189.2K +66.4K (+54.1%) | 414.3K +127.0K (+44.2%) | 0.19% +0.065 pp | 0.00% +0.000 pp | USD2.97 -26.3% | 11 qtrs — |
| 39 | JANE STREET GROUP, LLC | 179.1K -11.1K (-5.8%) | 392.2K -52.8K (-11.9%) | 0.18% -0.011 pp | 0.00% +0.000 pp | USD2.00 +9.5% | 5 qtrs — |
| 40 | STONEPINE CAPITAL MANAGEMENT, LLC | 171.1K +171.1K (+100.0%) | 374.7K +374.7K (+100.0%) | 0.17% +0.167 pp | 0.27% +0.274 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 41 | XTX TOPCO LTD | 155.4K -128.9K (-45.3%) | 340.3K -325.0K (-48.8%) | 0.15% -0.126 pp | 0.01% -0.026 pp | USD2.06 +6.3% | 3 qtrs — |
| 42 | GRAHAM CAPITAL MANAGEMENT, L.P. | 151.5K +151.5K (+100.0%) | 331.7K +331.7K (+100.0%) | 0.15% +0.148 pp | 0.01% +0.008 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 43 | SQUAREPOINT OPS LLC | 149.1K +137.2K (+1,156.3%) | 326.5K +298.7K (+1,075.7%) | 0.15% +0.134 pp | 0.00% +0.000 pp | USD2.14 +2.3% | 12 qtrs — |
| 44 | HUDSON BAY CAPITAL MANAGEMENT LP | 138.7K +138.7K (+100.0%) | 303.8K +303.8K (+100.0%) | 0.14% +0.136 pp | 0.00% +0.001 pp | USD2.19 +0.0% | 3 qtrs — |
| 45 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 138.3K -233.8K (-62.8%) | 302.8K -567.9K (-65.2%) | 0.14% -0.229 pp | 0.00% 0.000 pp | USD2.32 -5.6% | 9 qtrs — |
| 46 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 130.7K +35.0K (+36.6%) | 286.2K +62.3K (+27.8%) | 0.13% +0.034 pp | 0.01% +0.001 pp | USD2.28 -3.9% | 5 qtrs — |
| 47 | OMERS ADMINISTRATION CORP | 95.4K +95.4K (+100.0%) | 208.9K +208.9K (+100.0%) | 0.09% +0.093 pp | 0.00% +0.002 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 48 | LETKO, BROSSEAU & ASSOCIATES INC | 90.5K +90.5K (+100.0%) | 198.1K +198.1K (+100.0%) | 0.09% +0.089 pp | 0.00% +0.003 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 49 | TD ASSET MANAGEMENT INC | 88.6K +— (+0.0%) | 194.0K -13.3K (-6.4%) | 0.09% +0.000 pp | 0.00% +0.000 pp | USD20.46 -89.3% | 9 qtrs — |
| 50 | CITIGROUP INC | 73.8K +73.4K (+20,858.5%) | 161.6K +160.7K (+19,507.4%) | 0.07% +0.072 pp | 0.00% +0.000 pp | USD2.21 -0.9% | 12 qtrs — |
| 51 | DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 66.8K +66.8K (+100.0%) | 146.0K +146.0K (+100.0%) | 0.07% +0.065 pp | 0.03% +0.033 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 52 | QUADRATURE CAPITAL LTD | 66.4K +23.5K (+54.7%) | 145.4K +45.0K (+44.8%) | 0.06% +0.023 pp | 0.00% +0.000 pp | USD2.29 -4.4% | 2 qtrs — |
| 53 | AMERICAN CENTURY COMPANIES INC | 58.8K +46.7K (+388.5%) | 128.7K +100.6K (+357.2%) | 0.06% +0.046 pp | 0.00% +0.000 pp | USD2.22 -1.4% | 2 qtrs — |
| 54 | POINT72 ASSET MANAGEMENT, L.P. | 56.6K +56.6K (+100.0%) | 124.1K +124.1K (+100.0%) | 0.06% +0.055 pp | 0.00% +0.000 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 55 | MATAURO, LLC | 55.1K +55.1K (+100.0%) | 120.7K +120.7K (+100.0%) | 0.05% +0.054 pp | 0.02% +0.018 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 56 | BANK OF NEW YORK MELLON CORP | 54.0K +6.2K (+13.0%) | 118.4K +6.5K (+5.8%) | 0.05% +0.006 pp | 0.00% +0.000 pp | USD9.83 -77.7% | 25 qtrs — |
| 57 | BALYASNY ASSET MANAGEMENT L.P. | 51.6K +51.6K (+100.0%) | 112.9K +112.9K (+100.0%) | 0.05% +0.050 pp | 0.00% +0.000 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 58 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 50.8K +— (+0.0%) | 111.3K -7.6K (-6.4%) | 0.05% +0.000 pp | 0.00% +0.000 pp | USD8.37 -73.8% | 13 qtrs — |
| 59 | JEFFERIES FINANCIAL GROUP INC. | 45.1K -2.4K (-5.0%) | 98.8K -12.3K (-11.1%) | 0.04% -0.002 pp | 0.00% +0.000 pp | USD1.52 +44.1% | 3 qtrs — |
| 60 | LPL FINANCIAL LLC | 42.6K +42.6K (+100.0%) | 93.3K +93.3K (+100.0%) | 0.04% +0.042 pp | 0.00% +0.000 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 61 | LIGHTHOUSE INVESTMENT PARTNERS, LLC | 38.9K +38.9K (+100.0%) | 85.1K +85.1K (+100.0%) | 0.04% +0.038 pp | 0.00% +0.003 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 62 | SG AMERICAS SECURITIES, LLC | 30.6K +9.4K (+44.0%) | 67.0K +17.0K (+34.0%) | 0.03% +0.009 pp | 0.00% 0.000 pp | USD3.63 -39.7% | 6 qtrs — |
| 63 | TOWER RESEARCH CAPITAL LLC (TRC) | 30.3K +26.0K (+594.9%) | 66.5K +56.2K (+550.3%) | 0.03% +0.025 pp | 0.00% +0.001 pp | USD2.20 -0.5% | 25 qtrs — |
| 64 | FRED ALGER MANAGEMENT, LLC | 28.0K -31.8K (-53.2%) | 61.4K -78.6K (-56.2%) | 0.03% -0.031 pp | 0.00% 0.000 pp | USD7.34 -70.2% | 13 qtrs — |
| 65 | MERCER GLOBAL ADVISORS INC /ADV | 26.5K +26.5K (+100.0%) | 58.1K +58.1K (+100.0%) | 0.03% +0.026 pp | 0.00% +0.000 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 66 | CALLAN FAMILY OFFICE, LLC | 22.6K +22.6K (+100.0%) | 49.4K +49.4K (+100.0%) | 0.02% +0.022 pp | 0.00% +0.001 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 67 | VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 22.4K +233.0 (+1.1%) | 49.0K -2.8K (-5.4%) | 0.02% +0.000 pp | 0.00% 0.000 pp | USD3.06 -28.4% | 6 qtrs — |
| 68 | JONES FINANCIAL COMPANIES LLLP | 20.7K +653.0 (+3.3%) | 45.2K -2.0K (-4.2%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD2.34 -6.4% | 5 qtrs — |
| 69 | CLEAR HARBOR ASSET MANAGEMENT, LLC | 19.5K +19.5K (+100.0%) | 42.7K +42.7K (+100.0%) | 0.02% +0.019 pp | 0.00% +0.003 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 70 | ANTIPODES PARTNERS LTD | 17.2K +17.2K (+100.0%) | 37.6K +37.6K (+100.0%) | 0.02% +0.017 pp | 0.00% +0.001 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 71 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 15.7K +15.7K (+100.0%) | 34.4K +34.4K (+100.0%) | 0.02% +0.015 pp | 0.00% +0.003 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 72 | CRA FINANCIAL SERVICES, LLC | 15.0K +— (+0.0%) | 32.9K -2.3K (-6.4%) | 0.01% +0.000 pp | 0.00% -0.001 pp | USD1.64 +33.5% | 4 qtrs — |
| 73 | PRIVATE ADVISOR GROUP, LLC | 14.7K +14.7K (+100.0%) | 32.2K +32.2K (+100.0%) | 0.01% +0.014 pp | 0.00% +0.000 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 74 | BANK OF AMERICA CORP /DE/ | 14.4K -253.7K (-94.6%) | 31.5K -595.7K (-95.0%) | 0.01% -0.419 pp | 0.00% +0.000 pp | USD4.99 -56.1% | 25 qtrs — |
| 75 | FMR LLC | 13.0K -1.0K (-7.2%) | 28.6K -4.3K (-13.2%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD1.81 +21.0% | 12 qtrs — |
| 76 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 13.0K -73.0 (-0.6%) | 28.0K -2.6K (-8.4%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD19.06 -88.5% | 11 qtrs — |
| 77 | HB WEALTH MANAGEMENT, LLC | 10.0K +10.0K (+100.0%) | 21.9K +21.9K (+100.0%) | 0.01% +0.010 pp | 0.00% +0.000 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 78 | JPMORGAN CHASE & CO | 9.8K -527.8K (-98.2%) | 21.5K -1.2M (-98.3%) | 0.01% -0.859 pp | 0.00% 0.000 pp | USD3.20 -31.6% | 25 qtrs — |
| 79 | MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 4.7K +4.7K (+100.0%) | 10.2K +10.2K (+100.0%) | 0.00% +0.005 pp | 0.00% +0.000 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 80 | PNC FINANCIAL SERVICES GROUP, INC. | 4.6K +4.0K (+666.7%) | 10.1K +8.7K (+617.5%) | 0.00% +0.004 pp | 0.00% +0.000 pp | USD2.11 +3.8% | 12 qtrs — |
| 81 | CANADA PENSION PLAN INVESTMENT BOARD | 3.5K +3.5K (+100.0%) | 7.7K +7.7K (+100.0%) | 0.00% +0.003 pp | 0.00% +0.000 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 82 | WELLS FARGO & COMPANY/MN | 2.0K -1.0K (-33.3%) | 4.4K -2.6K (-37.6%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD7.26 -69.8% | 25 qtrs — |
| 83 | GF FUND MANAGEMENT CO. LTD. | 1.9K +1.9K (+100.0%) | 4.1K +4.1K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 84 | BNP PARIBAS ARBITRAGE, SNC | 1.6K -191.0 (-10.4%) | 3.6K -693.0 (-16.2%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.13 +2.8% | 5 qtrs — |
| 85 | FLAGSHIP HARBOR ADVISORS, LLC | 1.0K +1.0K (+100.0%) | 2.2K +2.2K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD2.19 +0.0% | 1 qtrs NEW |
| 86 | RUSSELL INVESTMENTS GROUP, LTD. | 939.00 +— (+0.0%) | 2.1K -141.0 (-6.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.52 +44.1% | 10 qtrs — |
| 87 | NISA INVESTMENT ADVISORS, LLC | 811.00 +— (+0.0%) | 1.8K -122.0 (-6.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.74 -20.1% | 10 qtrs — |
| 88 | TRUVESTMENTS CAPITAL LLC | 680.00 +— (+0.0%) | 1.5K -102.0 (-6.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.07 -28.7% | 6 qtrs — |
| 89 | FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 340.00 +— (+0.0%) | 745.00 -51.0 (-6.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD11.10 -80.3% | 20 qtrs — |
| 90 | SBI SECURITIES CO., LTD. | 316.00 -140.0 (-30.7%) | 692.00 -375.0 (-35.1%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.46 +50.0% | 5 qtrs — |
| 91 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 60.00 +58.0 (+2,900.0%) | 131.00 +126.0 (+2,520.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.18 +0.5% | 2 qtrs — |
| 92 | OPTIVER HOLDING B.V. | 24.00 +— (+0.0%) | 53.00 -3.0 (-5.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.33 -6.0% | 2 qtrs — |
| 93 | SRS CAPITAL ADVISORS, INC. | 10.00 +— (+0.0%) | 22.00 -1.0 (-4.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.30 -4.8% | 2 qtrs — |
| 94 | HEIGHTS CAPITAL MANAGEMENT, INC | — -2.1M (-100.0%) | — -4.9M (-100.0%) | 0.00% -2.038 pp | 0.00% -1.337 pp | USD— | 3 qtrs SOLD |
| 95 | FEDERATED HERMES, INC. | — -112.0K (-100.0%) | — -262.1K (-100.0%) | 0.00% -0.110 pp | 0.00% -0.001 pp | USD— | 6 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 62 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Virtus Biotech Clinical Trials ETF BBC | 0.61% | 350.2K | 0.65% |
| 2 | Global X - S&P Biotech ETF CURE.AX | 0.15% | 52.2K | 0.45% |
| 3 | State Street SPDR S&P Biotech ETF XBI | 0.14% | 15.68M | 0.35% |
| 4 | iShares Micro-Cap ETF IWC | 0.07% | 1.11M | 0.60% |
| 5 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.03% | 154.4K | 0.40% |
| 6 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.03% | 24.9K | 0.19% |
| 7 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.03% | 365.5K | 0.35% |
| 8 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.03% | 24.5K | 0.35% |
| 9 | iShares Biotechnology ETF IBB | 0.03% | 3.05M | 0.44% |
| 10 | Pacer WealthShield ETF PWS | 0.03% | 7.3K | 0.60% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
14
Sells
0
Shares acquired
1.83M
Shares disposed
—
Cash buys
8.00
Cash sales
—
Net activity
+1,831,073
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | Nichtberger Steven | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 674,000 | 3.30 | 2.22M | 674,000 | D | ↗ |
| 2026-03-02 | Marda Anup | Officer | A-Award | A | Stock Option (Right to Buy) | 225,000 | 3.30 | 742.5K | 225,000 | D | ↗ |
| 2026-03-02 | Gerard Michael | Officer | A-Award | A | Stock Option (Right to Buy) | 175,000 | 3.30 | 577.5K | 175,000 | D | ↗ |
| 2026-03-02 | Das Arun | Officer | A-Award | A | Stock Option (Right to Buy) | 175,000 | 3.30 | 577.5K | 175,000 | D | ↗ |
| 2026-03-02 | Chang David J. | Officer | A-Award | A | Stock Option (Right to Buy) | 225,000 | 3.30 | 742.5K | 225,000 | D | ↗ |
| 2026-03-02 | Binder Gwendolyn | Officer | A-Award | A | Stock Option (Right to Buy) | 225,000 | 3.30 | 742.5K | 225,000 | D | ↗ |
| 2026-01-21 | Tomasello Shawn | Director | P-Purchase | A | Common Stock | 22,725 | 2.21 | 50.3K | 22,725 | I | ↗ |
| 2026-01-21 | Simon Mark | Director | P-Purchase | A | Common Stock | 11,061 | 2.28 | 25.3K | 147,205 | D | ↗ |
| 2026-01-21 | Nichtberger Steven | Director / Officer | P-Purchase | A | Common Stock | 45,000 | 2.24 | 100.8K | 1,031,483 | D | ↗ |
| 2026-01-21 | Gerard Michael | Officer | P-Purchase | A | Common Stock | 6,600 | 2.27 | 15.0K | 6,600 | D | ↗ |
| 2026-01-21 | Gavel Steve | Officer | P-Purchase | A | Common Stock | 22,170 | 2.27 | 50.2K | 22,170 | D | ↗ |
| 2026-01-21 | Chang David J. | Officer | P-Purchase | A | Common Stock | 8,800 | 2.26 | 19.9K | 8,800 | D | ↗ |
| 2026-01-21 | Bollard Catherine | Director | P-Purchase | A | Common Stock | 4,405 | 2.27 | 10.0K | 5,405 | D | ↗ |
| 2026-01-21 | Binder Gwendolyn | Officer | P-Purchase | A | Common Stock | 11,312 | 2.19 | 24.8K | 31,312 | D | ↗ |
| 2025-10-13 | Gavel Steve | Officer | A-Award | A | Stock Option (Right to Buy) | 275,000 | 2.49 | 684.8K | 275,000 | D | ↗ |
| 2025-06-09 | Tomasello Shawn | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 2.37 | 52.1K | 22,000 | D | ↗ |
| 2025-06-09 | Simon Mark | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 2.37 | 52.1K | 22,000 | D | ↗ |
| 2025-06-09 | HENRIQUES RICHARD C JR | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 2.37 | 52.1K | 22,000 | D | ↗ |
| 2025-06-09 | Brun Scott C. | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 2.37 | 52.1K | 22,000 | D | ↗ |
| 2025-06-09 | Bollard Catherine | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 2.37 | 52.1K | 22,000 | D | ↗ |
| 2025-05-19 | Tomasello Shawn | Director | D-Return | D | Stock Option (Right to Buy) | 22,000 | 10.01 | 220.2K | 0 | D | ↗ |
| 2025-05-19 | Simon Mark | Director | A-Award | A | Stock Option (Right to Buy) | 18,460 | 1.92 | 35.4K | 18,460 | D | ↗ |
| 2025-05-19 | Nichtberger Steven | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 99,714 | 1.92 | 191.5K | 99,714 | D | ↗ |
| 2025-05-19 | Marda Anup | Officer | D-Return | D | Stock Option (Right to Buy) | 100,000 | 11.47 | 1.15M | 0 | D | ↗ |
| 2025-05-19 | HENRIQUES RICHARD C JR | Director | A-Award | A | Stock Option (Right to Buy) | 46,428 | 1.92 | 89.1K | 46,428 | D | ↗ |
| 2025-05-19 | Gerard Michael | Officer | D-Return | D | Stock Option (Right to Buy) | 100,000 | 10.93 | 1.09M | 0 | D | ↗ |
| 2025-05-19 | Das Arun | Officer | A-Award | A | Stock Option (Right to Buy) | 18,416 | 1.92 | 35.4K | 18,416 | D | ↗ |
| 2025-05-19 | Chang David J. | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 1.92 | 288.0K | 150,000 | D | ↗ |
| 2025-05-19 | Brun Scott C. | Director | D-Return | D | Stock Option (Right to Buy) | 22,000 | 10.01 | 220.2K | 0 | D | ↗ |
| 2025-05-19 | Bollard Catherine | Director | D-Return | D | Stock Option (Right to Buy) | 46,428 | 6.30 | 292.5K | 0 | D | ↗ |
| 2025-05-19 | Binder Gwendolyn | Officer | A-Award | A | Stock Option (Right to Buy) | 29,908 | 1.92 | 57.4K | 29,908 | D | ↗ |
| 2025-03-03 | Nichtberger Steven | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 450,000 | 1.67 | 751.5K | 450,000 | D | ↗ |
| 2025-03-03 | Marda Anup | Officer | A-Award | A | Stock Option (Right to Buy) | 145,000 | 1.67 | 242.2K | 145,000 | D | ↗ |
| 2025-03-03 | Gerard Michael | Officer | A-Award | A | Stock Option (Right to Buy) | 115,000 | 1.67 | 192.1K | 115,000 | D | ↗ |
| 2025-03-03 | Das Arun | Officer | A-Award | A | Stock Option (Right to Buy) | 115,000 | 1.67 | 192.1K | 115,000 | D | ↗ |
| 2025-03-03 | Chang David J. | Officer | A-Award | A | Stock Option (Right to Buy) | 145,000 | 1.67 | 242.2K | 145,000 | D | ↗ |
| 2025-03-03 | Binder Gwendolyn | Officer | A-Award | A | Stock Option (Right to Buy) | 145,000 | 1.67 | 242.2K | 145,000 | D | ↗ |
| 2024-06-03 | Tomasello Shawn | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 10.01 | 220.2K | 22,000 | — | ↗ |
| 2024-06-03 | Simon Mark | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 10.01 | 220.2K | 22,000 | — | ↗ |
| 2024-06-03 | HENRIQUES RICHARD C JR | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 10.01 | 220.2K | 22,000 | — | ↗ |
| 2024-06-03 | Brun Scott C. | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 10.01 | 220.2K | 22,000 | — | ↗ |
| 2024-06-03 | Bollard Catherine | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 10.01 | 220.2K | 22,000 | — | ↗ |
| 2024-03-01 | Nichtberger Steven | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 353,000 | 23.97 | 8.46M | 353,000 | — | ↗ |
| 2024-03-01 | Marda Anup | Officer | A-Award | A | Stock Option (Right to Buy) | 130,000 | 23.97 | 3.12M | 130,000 | — | ↗ |
| 2024-03-01 | Gerard Michael | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 23.97 | 2.40M | 100,000 | — | ↗ |
| 2024-03-01 | Das Arun | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 23.97 | 2.40M | 100,000 | — | ↗ |
| 2024-03-01 | Chang David J. | Officer | A-Award | A | Stock Option (Right to Buy) | 130,000 | 23.97 | 3.12M | 130,000 | — | ↗ |
| 2024-03-01 | Binder Gwendolyn | Officer | A-Award | A | Stock Option (Right to Buy) | 130,000 | 23.97 | 3.12M | 130,000 | — | ↗ |
| 2024-01-19 | Binder Gwendolyn | Officer | M-Exempt | D | Stock Option (Right to Buy) | 11,000 | 1.01 | 11.1K | 100,756 | — | ↗ |
| 2023-12-19 | Binder Gwendolyn | Officer | M-Exempt | D | Stock Option (Right to Buy) | 11,000 | 1.01 | 11.1K | 111,756 | — | ↗ |
| 2023-11-20 | Binder Gwendolyn | Officer | M-Exempt | D | Stock Option (Right to Buy) | 11,000 | 1.01 | 11.1K | 122,756 | — | ↗ |
| 2023-10-19 | Binder Gwendolyn | Officer | S-Sale | D | Common Stock | 408 | 14.28 | 5.8K | 20,000 | — | ↗ |
| 2023-09-19 | Binder Gwendolyn | Officer | S-Sale | D | Common Stock | 10,300 | 17.50 | 180.3K | 20,700 | — | ↗ |
| 2023-08-21 | Binder Gwendolyn | Officer | M-Exempt | D | Stock Option (Right to Buy) | 11,000 | 1.01 | 11.1K | 155,756 | — | ↗ |
| 2023-07-21 | Tomasello Shawn | Director | A-Award | A | Stock Option (Right to Buy) | 44,000 | 13.48 | 593.1K | 44,000 | — | ↗ |
| 2023-07-19 | Binder Gwendolyn | Officer | M-Exempt | D | Stock Option (Right to Buy) | 11,000 | 1.01 | 11.1K | 166,756 | — | ↗ |
| 2023-06-20 | Binder Gwendolyn | Officer | S-Sale | D | Common Stock | 11,000 | 12.99 | 142.9K | 20,000 | — | ↗ |
| 2023-06-01 | Simon Mark | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 11.18 | 246.0K | 22,000 | — | ↗ |
| 2023-06-01 | HENRIQUES RICHARD C JR | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 11.18 | 246.0K | 22,000 | — | ↗ |
| 2023-06-01 | Brun Scott C. | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 11.18 | 246.0K | 22,000 | — | ↗ |
| 2023-06-01 | Bollard Catherine | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 11.18 | 246.0K | 22,000 | — | ↗ |
| 2023-05-19 | Binder Gwendolyn | Officer | M-Exempt | D | Stock Option (Right to Buy) | 22,000 | 1.01 | 22.2K | 188,756 | — | ↗ |
| 2023-01-18 | Nichtberger Steven | Officer | A-Award | A | Stock Option (Right to Buy) | 411,600 | 0.00 | — | 411,600 | — | ↗ |
| 2023-01-18 | Marda Anup | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 0.00 | — | 150,000 | — | ↗ |
| 2023-01-18 | Gerard Michael | Officer | A-Award | A | Stock Option (Right to Buy) | 112,500 | 0.00 | — | 112,500 | — | ↗ |
| 2023-01-18 | Das Arun | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 0.00 | — | 150,000 | — | ↗ |
| 2023-01-18 | Chang David J. | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 0.00 | — | 150,000 | — | ↗ |
| 2023-01-18 | Binder Gwendolyn | Officer | A-Award | A | Stock Option (Right to Buy) | 176,000 | 0.00 | — | 176,000 | — | ↗ |
| 2022-10-19 | Nichtberger Steven | Officer | P-Purchase | A | Common Stock | 8,127 | 1.25 | 10.2K | 986,483 | — | ↗ |
| 2022-10-18 | Simon Mark | Director | P-Purchase | A | Common Stock | 7,000 | 0.98 | 6.8K | 7,000 | — | ↗ |
| 2022-10-18 | Nichtberger Steven | Officer | P-Purchase | A | Common Stock | 141,873 | 0.99 | 141.0K | 978,356 | — | ↗ |
| 2022-10-18 | Marda Anup | Officer | P-Purchase | A | Common Stock | 50,000 | 0.99 | 49.6K | 50,000 | — | ↗ |
| 2022-10-18 | Bollard Catherine | Director | P-Purchase | A | Common Stock | 1,000 | 0.99 | 993.50 | 1,000 | — | ↗ |
| 2022-10-18 | Binder Gwendolyn | Officer | P-Purchase | A | Common Stock | 20,000 | 0.99 | 19.9K | 20,000 | — | ↗ |
| 2022-06-01 | Simon Mark | Director | A-Award | A | Stock Option (Right to buy) | 22,000 | 1.28 | 28.2K | 22,000 | — | ↗ |
| 2022-06-01 | HENRIQUES RICHARD C JR | Director | A-Award | A | Stock Option (Right to buy) | 22,000 | 0.00 | — | 22,000 | — | ↗ |
| 2022-06-01 | Brun Scott C. | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 0.00 | — | 22,000 | — | ↗ |
| 2022-06-01 | Bollard Catherine | Director | A-Award | A | Stock Option (Right to buy) | 22,000 | 0.00 | — | 22,000 | — | ↗ |
| 2022-01-31 | Nichtberger Steven | Director / Officer | M-Exempt | A | Common Stock | 50,000 | 1.01 | 50.5K | 836,483 | — | ↗ |
| 2022-01-18 | Nichtberger Steven | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 380,000 | 3.21 | 1.22M | 380,000 | — | ↗ |
| 2022-01-18 | Marda Anup | Officer | A-Award | A | Stock Option (Right to Buy) | 135,000 | 3.21 | 433.4K | 135,000 | — | ↗ |
| 2022-01-18 | Gerard Michael | Officer | A-Award | A | Stock Option (Right to Buy) | 75,000 | 3.21 | 240.8K | 75,000 | — | ↗ |
| 2022-01-18 | Das Arun | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 3.21 | 321.0K | 100,000 | — | ↗ |
| 2022-01-18 | Chang David J. | Officer | A-Award | A | Stock Option (Right to Buy) | 135,000 | 3.21 | 433.4K | 135,000 | — | ↗ |
| 2022-01-18 | Binder Gwendolyn | Officer | A-Award | A | Stock Option (Right to Buy) | 160,000 | 3.21 | 513.6K | 160,000 | — | ↗ |
| 2022-01-05 | Das Arun | Officer | — | D | Stock Option (Right to Buy) | 18,416 | 11.00 | 202.6K | 0 | — | ↗ |
| 2021-11-01 | 5AM Ventures V, L.P. | 10% Owner | S-Sale | D | Common Stock | 258,456 | 13.00 | 3.36M | 1,731,119 | — | ↗ |
| 2021-09-07 | 5AM Ventures V, L.P. | 10% Owner | S-Sale | D | Common Stock | 625,000 | 9.70 | 6.06M | 1,989,575 | — | ↗ |
| 2021-09-01 | Gerard Michael | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 10.93 | 1.09M | 100,000 | — | ↗ |
| 2021-06-24 | Brun Scott C. | Director | A-Award | A | Stock Option (Right to Buy) | 44,000 | 7.35 | 323.4K | 44,000 | — | ↗ |
| 2021-06-01 | Simon Mark | Director | A-Award | A | Stock Option (Right to buy) | 22,000 | 11.00 | 242.0K | 22,000 | — | ↗ |
| 2021-06-01 | HENRIQUES RICHARD C JR | Director | A-Award | A | Stock Option (Right to buy) | 22,000 | 11.00 | 242.0K | 22,000 | — | ↗ |
| 2021-06-01 | DANIELS BRIAN | Director | A-Award | A | Stock Option (Right to buy) | 22,000 | 11.00 | 242.0K | 22,000 | — | ↗ |
| 2021-06-01 | Bollard Catherine | Director | A-Award | A | Stock Option (Right to buy) | 22,000 | 11.00 | 242.0K | 22,000 | — | ↗ |
| 2021-03-01 | Stalter John Brian | Officer | A-Award | A | Stock Option (Right to Buy) | 64,500 | 11.47 | 739.8K | 64,500 | — | ↗ |
| 2021-03-01 | Nichtberger Steven | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 333,500 | 11.47 | 3.83M | 333,500 | — | ↗ |
| 2021-03-01 | Marda Anup | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 11.47 | 1.15M | 100,000 | — | ↗ |
| 2021-03-01 | Chang David J. | Officer | A-Award | A | Stock Option (Right to Buy) | 113,500 | 11.47 | 1.30M | 113,500 | — | ↗ |
| 2021-03-01 | Binder Gwendolyn | Officer | A-Award | A | Stock Option (Right to Buy) | 125,000 | 11.47 | 1.43M | 125,000 | — | ↗ |
| 2021-01-12 | 5AM Ventures V, L.P. | 10% Owner | S-Sale | D | Common Stock | 74,470 | 13.00 | 968.1K | 2,614,575 | — | ↗ |
| 2021-01-08 | 5AM Ventures V, L.P. | 10% Owner | S-Sale | D | Common Stock | 264,589 | 13.00 | 3.44M | 2,689,045 | — | ↗ |
| 2020-12-10 | 5AM Ventures V, L.P. | 10% Owner | S-Sale | D | Common Stock | 261,084 | 14.75 | 3.85M | 2,953,634 | — | ↗ |
| 2020-12-08 | Nichtberger Steven | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 93,226 | 1.01 | 94.2K | 93,226 | — | ↗ |
| 2020-09-14 | Stalter John Brian | Officer | A-Award | A | Stock Option (Right to Buy) | 60,000 | 12.01 | 720.6K | 60,000 | — | ↗ |
| 2020-03-01 | Nichtberger Steven | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 300,000 | 14.94 | 4.48M | 300,000 | — | ↗ |
| 2020-03-01 | Marda Anup | Officer | A-Award | A | Stock Option (Right to Buy) | 24,711 | 14.94 | 369.2K | 24,711 | — | ↗ |
| 2020-03-01 | Chang David J. | Officer | A-Award | A | Stock Option (Right to Buy) | 38,238 | 14.94 | 571.3K | 38,238 | — | ↗ |
| 2020-02-11 | DANIELS BRIAN | Director | A-Award | A | Stock Option (Right to Buy) | 44,000 | 15.42 | 678.5K | 44,000 | — | ↗ |
| 2019-12-31 | Nichtberger Steven | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 786,483 | — | ↗ |
| 2019-12-11 | Nichtberger Steven | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 93,225 | 1.01 | 94.2K | 93,225 | — | ↗ |
| 2019-10-29 | Simon Mark | Director | C-Conversion | D | Series A-1 Preferred Stock | 27,217 | 0.00 | — | 0 | — | ↗ |
| 2019-10-29 | Redmile Group, LLC | 10% Owner | C-Conversion | D | Series B Convertible Preferred Stock | 1,044,568 | 0.00 | — | 0 | — | ↗ |
| 2019-10-29 | Nichtberger Steven | Director / Officer | C-Conversion | D | Series A-1 Preferred Stock | 90,725 | 0.00 | — | 0 | — | ↗ |
| 2019-10-29 | Flynn James E | 10% Owner | C-Conversion | D | Series B Preferred Stock | 696,379 | 0.00 | — | 0 | — | ↗ |
| 2019-10-29 | 5AM Ventures V, L.P. | 10% Owner | C-Conversion | D | Series B Preferred Stock | 1,675,532 | 0.00 | — | 0 | — | ↗ |
| 2019-10-24 | Stalter John Brian | Officer | — | D | Stock Option (Right to Buy) | 112,559 | 9.54 | 1.07M | 0 | — | ↗ |
| 2019-10-24 | Simon Mark | Director | — | D | Stock Option (Right to Buy) | 18,460 | 6.30 | 116.3K | 0 | — | ↗ |
| 2019-10-24 | Redmile Group, LLC | 10% Owner | — | I | Series B Convertible Preferred Stock | 696,378 | 0.00 | — | 0 | — | ↗ |
| 2019-10-24 | Nichtberger Steven | Director / Officer | — | I | Common Stock | 0 | 0.00 | — | 363,000 | — | ↗ |
| 2019-10-24 | Marda Anup | Officer | — | D | Stock Option (Right to Buy) | 139,282 | 4.23 | 589.2K | 0 | — | ↗ |
| 2019-10-24 | HENRIQUES RICHARD C JR | Director | — | D | Stock Option (Right to Buy) | 46,428 | 6.30 | 292.5K | 0 | — | ↗ |
| 2019-10-24 | Flynn James E | 10% Owner | — | I | Series B Preferred Stock | 464,253 | 0.00 | — | 0 | — | ↗ |
| 2019-10-24 | DANIELS BRIAN | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-10-24 | Chang David J. | Officer | — | D | Stock Option (Right to Buy) | 185,709 | 6.30 | 1.17M | 0 | — | ↗ |
| 2019-10-24 | Bollard Catherine | Director | — | D | Stock Option (Right to Buy) | 46,428 | 6.30 | 292.5K | 0 | — | ↗ |
| 2019-10-24 | Binder Gwendolyn | Officer | — | D | Stock Option (Right to Buy) | 66,667 | 9.54 | 636.0K | 0 | — | ↗ |
| 2019-10-24 | 5AM Ventures V, L.P. | 10% Owner | — | I | Series A Preferred Stock | 3,146,551 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
96.27M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Steven A. Nichtberger | Co-Founder, Chairman, Chief Executive Officer & President | 1M | — |
| David J. Chang FACR | Chief Medical Officer | 807.1K | — |
| Gwendolyn K. Binder | President of Science & Technology | 774.0K | — |
| Anup Marda | Chief Financial Officer | 548.2K | male |
| Nicolette D. Sherman SPHR | Chief Human Resources Officer | — | female |
| Qing Sarah Yuan | Chief Technology Officer | — | — |
| Samik Basu | Chief Scientific Officer | — | — |
| Aimee Payne | Co-Founder & Co-Chair of Scientific Advisory Board | — | — |
| Steven J. Gavel | Chief Commercial Officer | — | male |
| Heather Harte-Hall | Chief Compliance Officer | — | female |
| Michael C. Milone | Co-Founder & Co-Chair of Scientific Advisory Board | — | — |
| Michael Gerard | General Counsel & Secretary | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CABA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
